Neuropace Inc
NPCE8.990USD
0.000
交易中 （美東）報價延遲15分鐘
294.43M總市值
虧損本益比TTM
關於 Neuropace Inc 公司
NeuroPace, Inc. 是一家醫療設備公司。該公司致力於通過減少或消除使人衰弱的癲癇發作來改變癲癇患者的生活。其新穎且差異化的 RNS 系統是一個大腦響應平臺，可在癲癇發作源頭提供個性化的實時治療。該公司開發了 RNS 系統來解決耐藥性癲癇的個性化性質，併爲大腦任何部位的局竈性癲癇發作提供安全的治療。RNS 系統是一種記錄大腦活動數據的設備，允許臨牀醫生不僅親自監測患者，還可以遠程監測患者。RNS 系統監測和分析大腦的電活動，識別患者特定的異常模式，並在癲癇發作源頭提供治療。該公司的 RNS 系統還用於治療其他腦部疾病，包括抑鬱症、衝動控制障礙、記憶障礙和創傷後應激障礙。
公司簡介
公司代碼NPCE
公司名稱Neuropace Inc
上市日期Apr 22, 2021
CEOMr. Joel D. Becker
員工數量184
證券類型Ordinary Share
年結日Apr 22
公司地址455 N. Bernardo Avenue
城市MOUNTAIN VIEW
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編94043
電話16502372700
網址https://www.neuropace.com/
公司代碼NPCE
上市日期Apr 22, 2021
CEOMr. Joel D. Becker
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
589.53K
+0.39%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
74.39K
-1.77%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
--
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
37.35K
+2.98%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
15.59K
+10.17%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
12.04K
+10.46%
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Director
Independent Director
--
--
Ms. Renee Ryan
Ms. Renee Ryan
Independent Director
Independent Director
--
--
Mr. Joel D. Becker
Mr. Joel D. Becker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa Andrade
Ms. Lisa Andrade
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
589.53K
+0.39%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
74.39K
-1.77%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
--
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
37.35K
+2.98%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
15.59K
+10.17%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
12.04K
+10.46%
收入明細
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q1
FY2023
FY2022
FY2021
FY2020
FY2019
暫無數據
地區USD
名稱
營收
佔比
United States
22.52M
0.00%
業務
地區
暫無數據
股東統計
更新時間: 6月4日 週三
更新時間: 6月4日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Accelmed Growth Partners Management Ltd
13.52%
OrbiMed Advisors, LLC
10.39%
Soleus Capital Management, L.P.
7.95%
Morgan Stanley & Co. LLC
7.70%
Polar Capital LLP
7.62%
Other
52.83%
持股股東
持股股東
佔比
Accelmed Growth Partners Management Ltd
13.52%
OrbiMed Advisors, LLC
10.39%
Soleus Capital Management, L.P.
7.95%
Morgan Stanley & Co. LLC
7.70%
Polar Capital LLP
7.62%
Other
52.83%
股東類型
持股股東
佔比
Private Equity
23.90%
Hedge Fund
20.38%
Investment Advisor/Hedge Fund
19.42%
Investment Advisor
13.63%
Research Firm
8.48%
Individual Investor
2.75%
Pension Fund
0.40%
Bank and Trust
0.04%
Insurance Company
0.02%
Other
10.96%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
183
29.20M
89.03%
-971.50K
2025Q1
183
29.76M
92.98%
+2.27M
2024Q4
144
26.53M
86.07%
-49.99K
2024Q3
134
26.01M
86.62%
-1.02M
2024Q2
129
25.88M
90.53%
+502.69K
2024Q1
131
24.82M
87.55%
-513.24K
2023Q4
113
24.06M
92.70%
-1.70M
2023Q3
103
24.86M
97.20%
-1.10M
2023Q2
106
24.30M
96.22%
-2.15M
2023Q1
107
24.47M
97.75%
-1.64M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Accelmed Growth Partners Management Ltd
4.43M
13.52%
--
--
Apr 09, 2025
OrbiMed Advisors, LLC
3.41M
10.39%
--
--
Mar 31, 2025
Soleus Capital Management, L.P.
2.61M
7.95%
+175.00K
+7.19%
Mar 31, 2025
Morgan Stanley & Co. LLC
2.52M
7.7%
+38.83K
+1.56%
Mar 31, 2025
Polar Capital LLP
2.50M
7.62%
-472.00K
-15.88%
Apr 09, 2025
First Light Asset Management, LLC
1.58M
4.83%
+1.58M
--
Mar 31, 2025
The Vanguard Group, Inc.
1.20M
3.65%
+140.78K
+13.32%
Mar 31, 2025
Armistice Capital LLC
1.15M
3.52%
+561.00K
+94.67%
Mar 31, 2025
Kent Lake PR LLC
950.00K
2.9%
-532.55K
-35.92%
Mar 31, 2025
DWS Investments UK Limited
923.92K
2.82%
+511.66K
+124.11%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Neuroscience and Healthcare ETF
0.63%
iShares Micro-Cap ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 Growth ETF
0.02%
Principal U.S. Small-Cap ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Global X Russell 2000 ETF
0.01%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
查看更多
iShares Neuroscience and Healthcare ETF
佔比0.63%
iShares Micro-Cap ETF
佔比0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.03%
iShares Russell 2000 Growth ETF
佔比0.02%
Principal U.S. Small-Cap ETF
佔比0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
佔比0.01%
Global X Russell 2000 ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0.01%
iShares Russell 2000 ETF
佔比0.01%
ProShares UltraPro Russell2000
佔比0.01%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
